Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.5399 -0.0001 (-0.02%)
Streaming Delayed Price Updated: 10:18 AM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,746
Open 0.5344
Bid (Size) 0.5310 (9)
Ask (Size) 0.5400 (26)
Prev. Close 0.5400
Today's Range 0.5333 - 0.5500
52wk Range 0.4557 - 33.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study
Via ACCESSWIRE
Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones rose around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga

Performance

YTD
-32.51%
-32.51%
1 Month
+12.48%
+12.48%
3 Month
-25.47%
-25.47%
6 Month
-87.93%
-87.93%
1 Year
-97.50%
-97.50%

More News

Read More
Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar
Via ACCESSWIRE
ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Via Benzinga
Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock
Via ACCESSWIRE
Ensysce Biosciences Provides Corporate Update
Via ACCESSWIRE
Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
Via ACCESSWIRE
Ensysce Biosciences to Present its Overdose Protection Program at the 4th Annual NIH 'HELPING END ADDICTION LONG-TERM' (HEAL) Meeting
Via ACCESSWIRE
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules
Via ACCESSWIRE
Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering
Via ACCESSWIRE
Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock
Via ACCESSWIRE
Why Ensysce Biosciences Stock Is Exploding Higher During Wednesday's Session
Via Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
Via Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Ensysce Biosciences to Present at Diamond Equity Research 2023 Virtual Emerging Growth Invitational
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Ensysce Biosciences Issues 2023 Shareholder Letter
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.